Sign in to continue:

Friday, March 27th, 2026

GUOCHUN INTERNATIONAL INC. Files Form 8-K Current Report with SEC on March 26, 2026

Guochun International Inc. Issues 8-K: Announces Non-Reliance on Q3 2025 Financial Statements

MIAMI, FL – March 26, 2026 – Guochun International Inc. (OTC: GCGJ) filed a Form 8-K with the Securities and Exchange Commission (SEC) to notify investors and the market of a significant development regarding its previously issued financial statements. The company’s management has determined that investors should not rely on the unaudited condensed financial statements for the period ended September 30, 2025, as included in its last filed Form 10-Q. This decision could have material implications for shareholders and the stock’s valuation.

Key Points from the Filing

  • Restatement of Financial Statements: The Company has announced it will restate its unaudited condensed financial statements for the three and nine months ended September 30, 2025.
  • Nature of the Error: The restatement is aimed at correcting an erroneously recorded amount in other general and administrative expenses. Specifically, an expense was incorrectly recognized, which affected the company’s reported financial results for the period.
  • Financial Impact: The cumulative effect of correcting this error is a decrease in other general and administrative expenses by \$8,250, with a corresponding increase in prepayments by \$8,250. This means the company overstated its expenses and understated its assets in the original report.
  • Preliminary Determination: The company notes that these results are preliminary and subject to further revision, pending the filing of an amended Form 10-Q/A for the relevant period.
  • No Reliance Warning: Guochun International’s management has formally advised that investors, analysts, and other stakeholders should not rely on the previously issued Q3 2025 financial statements or related reports until the restatement is complete.

Potential Impact for Shareholders

  • Price Sensitive Information: The identification and correction of a financial reporting error is a material event that could impact investor confidence and the company’s valuation. Restatements often lead to increased scrutiny of a company’s internal controls and management oversight.
  • Stock Performance Risk: The market typically reacts to restatements with increased volatility, particularly if the restatement raises questions about the reliability of management’s reporting or internal controls.
  • Regulatory and Legal Implications: While this correction appears limited in dollar value (\$8,250), the company’s need to issue a non-reliance 8-K could trigger further regulatory review or investor concern, especially if this is part of a broader pattern.
  • No Securities Registered under 12(b): The company’s securities are not listed on a national securities exchange (such as NYSE or NASDAQ) but are traded on the OTC Markets under the symbol GCGJ.
  • Emerging Growth Company Status: Guochun International Inc. is not considered an emerging growth company as defined by the SEC.

What Investors Should Do

  • Exercise Caution: Investors are advised to exercise caution and await the filing of the amended Form 10-Q/A before making investment decisions based on the company’s Q3 2025 financials.
  • Monitor for Updates: Watch for further SEC filings from Guochun International Inc., including the restated financials and any comments from management or the company’s auditors regarding internal controls.
  • Assess Management’s Response: How quickly and transparently management resolves this matter may influence market perception and, ultimately, the stock price.

About Guochun International Inc.

Guochun International Inc. is a Nevada-incorporated company, currently operating in the field of computer programming, data processing, and related services. The company’s principal executive office is located at 66 West Flagler Street, Suite 900, #3040, Miami, FL 33130. The company was formerly known as Charmt, Inc.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. All investors are urged to read the full SEC filings and consult with their financial advisors before making investment decisions. The author and publisher make no representation or warranty as to the accuracy or completeness of the information contained herein and shall not be liable for any loss or damage arising from reliance on this report.

View GUOCHUN INTERNATIONAL INC. Historical chart here



Core & Main, Inc. 2026 Annual Report: Business Overview, Growth Strategies, Risks, and Financial Highlights

Core & Main, Inc. 2026 Annual Report: Key Investor Takeaways...

ProMIS Neurosciences 2025 Annual Report: Pipeline, Risks, and Strategic Objectives for Alzheimer’s Drug Development

ProMIS Neurosciences 2025 Annual Report: Key Investor Highli...

GoodRx Holdings, Inc. Announces Dismissal of PwC as Independent Auditor in March 2026

GoodRx Holdings, Inc. Announces Change in Independent Audito...

   Ad